Lowell Thomas Holden - 29 Dec 2023 Form 4 Insider Report for Nascent Biotech Inc.

Role
CFO, Director
Signature
/s/ Lowell Holden
Issuer symbol
NBIO on OTC
Transactions as of
29 Dec 2023
Net transactions value
+$20,340
Form type
4
Filing time
27 Feb 2024, 13:46:35 UTC
Previous filing
09 Nov 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $20,340 +119,650 +1.2% $0.1700* 9,796,977 29 Dec 2023 Direct F1
holding NBIO Common Stock 2,000,000 29 Dec 2023 Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.